OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Posting of Circular and Notice of General Meeting
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces, further to the announcement of 6 May 2022, a Circular containing details of the Open Offer and convening the General Meeting, together with a Form of Proxy will be posted to Shareholders today.
The General Meeting will be held at the offices of Shepherd & Wedderburn, 1 Exchange Crescent, Conference Square, Edinburgh, EH3 8UL at 11.00 a.m. on 6 June 2022. A copy of the Circular will today be made available on the Company's website: http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information
Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's announcement dated 6 May 2022.
Contacts:
|
Omega Diagnostics Group PLC |
|||
|
Jag Grewal, Chief Executive Officer |
via Walbrook PR |
||
|
Chris Lea, Chief Financial Officer |
|||
|
finnCap Ltd |
Tel: 020 7220 0500 |
||
|
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) |
|||
|
Alice Lane/ Harriet Ward (ECM) |
|||
|
Walbrook PR Limited |
Tel: 020 7933 8780 or omega@walbrookpr.com |
||
|
Paul McManus |
Mob: 07980 541 893 |
||
|
Lianne Applegarth |
Mob: 07584 391 303 |
||
|
Sam Allen |
Mob: 07502 558 258 |
||
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.